FINAL PROGR AM - American Society of Gene & Cell Therapy

More documents

Recommendations

Info

AMERICAN SOCIETY OF GENE THERAPY • Final Program 1 TABLE OF CONTENTS Welcome.................................................................................................................................................................... 2 Committee Meetings and Committee Rosters ...................................................................................................... 3 Annual Meeting Supporters .................................................................................................................................... 9 Annual Meeting Exhibitors.................................................................................................................................... 10 Abstract Reviewers ................................................................................................................................................. 11 Planning Committee and Group Coordinating Reviewers ................................................................................ 12 Research Awards and Travel Grant Recipients ..................................................................................................... 13 Faculty Listing ......................................................................................................................................................... 14 General Meeting Information ............................................................................................................................... 20 Program-at-a-Glance ............................................................................................................................................. 24 Scientific Program Schedule .................................................................................................................................. 25 America’s Center Floor Plans ................................................................................................................................ 42 Housing Information and Map of St. Louis ......................................................................................................... 44 Abstract Directory .................................................................................................................................................. 46 Abstract Author Index .......................................................................................................................................... 116 Exhibit Hall Floor Plan ........................................................................................................................................ 146 Exhibitor Information .......................................................................................................................................... 147 ASGT EXECUTIVE OFFICE 555 East Wells Street Suite 1100 Milwaukee, WI 53202-3823 Phone: (414) 278-1341 Fax: (414) 276-3349 E-mail: info@asgt.org Internet: www.asgt.org
2 8th Annual Meeting • June 1 - 5, 2005 • St. Louis Dear Colleagues, On behalf of the American Society of Gene Therapy, welcome to the ASGT 8 th Annual Meeting. We are very pleased to present this year’s program featuring the George Stamatoyannopoulos lecture by Thomas Tuschl, PhD, Mechanisms of siRNA- and miRNA-guided Gene Regulation in Mammals; the Presidential Symposium presentation by George Q. Daley, MD, PhD, Combining Gene Therapy with Cell Therapy; 18 Education Sessions; 16 Scientific Symposia; 17 Workshops; oral and poster sessions chosen from submitted abstracts and Meet-the-Investigator lunch sessions. This year, in response to feedback from previous years, the Young Investigators’ Symposium has been scheduled as a general session. The Society’s committees have done a great deal of hard work in putting together this superb program and for that, I thank them. Topics that will be covered at this year’s meeting include: Cancer Vaccines, Pre-Clinical Issues in Gene Therapy, Stem Cell Gene Therapy, Gene Therapy and Behavior, Skin Gene Therapy, Gene Therapy for HIV, Ethical Issues in Clinical Trial Design, Nonviral Gene Delivery, and Regenerative Approaches for Skeletal Disorders. Many other sessions cover the diverse and exciting developments in the field over the past year. I would like to thank our exhibitors and industry supporters for their participation and generosity, in addition to our exceptional faculty who kindly share their knowledge, expertise and time. The ASGT Annual Meeting provides an outstanding forum for sharing the latest developments in the field of gene therapy and networking with our colleagues. I welcome you to St. Louis. Sincerely, Katherine A. High, MD President, ASGT ASGT OFFICERS & DIRECTORS OFFICERS President Katherine A. High, MD The Children’s Hospital of Philadelphia Incoming President Mark A. Kay, MD, PhD Stanford University School of Medicine Vice President Theodore Friedmann, MD University of California San Diego School of Medicine Secretary (06) Kenneth Cornetta, MD Indiana University Treasurer (05) Xandra Breakefield, PhD Massachusetts General Hospital ASGT EXECUTIVE OFFICE 555 East Wells Street Suite 1100 Milwaukee, WI 53202 Phone: 414-278-1341 Fax: 414-276-3349 Email: info@asgt.org www.asgt.org Executive Director Elizabeth Dooley, CAE, CMP Director of Meetings & Communications Lynn Beyer Manager, Member Services Barbie Brennan Program Manager Ken Janowski Meetings & Exhibits Manager Nadine Kinnunen Additional On-Site Staff John Gardner Kelly Hughes Paul Rushizky Consulting Partner Kay Whalen, CAE BOARD OF DIRECTORS Jean Bennett, MD, PhD (07) Cynthia Dunbar, MD (05) John F. Engelhardt, PhD (06) Helen E. Heslop, MD (05) Nicholas Muzyczka, PhD (06) Paul D. Robbins, PhD (07) Michel Sadelain, MD, PhD (07) R. Jude Samulski, PhD (06) Jon Wolff, MD (05) Joseph C. Glorioso, PhD (05) Chair, Advisory Board (ex-officio) David A. Williams, MD Editor-in-Chief, Molecular Therapy (ex-officio)
Page 1: AMERICAN SOCIETY OF GENE THERAPY 8t
Page 5 and 6: 4 8th Annual Meeting • June 1 - 5
Page 11 and 12: 10 8th Annual Meeting • June 1 -
Page 53 and 54:
52 8th Annual Meeting • June 1 -
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
156 NOTES 8th Annual Meeting • Ju
show all

FINAL PROGR AM - American Society of Gene & Cell Therapy

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?